Tyrosine kinase inhibitor conjugated quantum dots for non‐small cell lung cancer (NSCLC) treatment
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.026
Development of the 1,2,4‐triazole‐based anticonvulsant drug candidates acting on the voltage‐gated sodium channels. Insights from in‐vivo, in‐vitro, and in‐silico studies
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.12.018
Hot melt extrusion technology for improved dissolution, solubility and “spring‐parachute” processes of amorphous self‐micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.019
A dynamic in vitro permeation study on solid mono‐ and diacyl‐phospholipid dispersions of celecoxib
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.003
Enhanced transdermal permeation and anti‐inflammatory potential of phospholipids complex‐loaded matrix film of umbelliferone: Formulation development, physico‐chemical and functional characterization
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.02.006
New thiobarbituric acid scaffold‐based small molecules: Synthesis, cytotoxicity, 2D‐QSAR, pharmacophore modelling and in‐silico ADME screening
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.023
Exploiting gelatin nanocarriers in the pulmonary delivery of methotrexate for lung cancer therapy
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.016
Solubility‐pH profile of desipramine hydrochloride in saline phosphate buffer: Enhanced solubility due to drug‐buffer aggregates
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.014
The use of heat and chemical penetration enhancers to increase the follicular delivery of erythromycin to the skin
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.02.030
Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.10.011
Evaluation of self‐nanoemulsifying drug delivery systems using multivariate methods to optimize permeability of captopril oral films
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.039
The EU regulatory landscape of non‐biological complex drugs (NBCDs) follow‐on products: Observations and recommendations
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.029
PD‐L1 knockdown via hybrid micelle promotes paclitaxel induced Cancer‐Immunity Cycle for melanoma treatment
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.10.021
Development of injectable liposomes and drug‐in‐cyclodextrin‐in‐liposome formulations encapsulating estetrol to prevent cerebral ischemia of premature babies
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.10.006
Further enhanced dissolution and oral bioavailability of docetaxel by coamorphization with a natural P‐gp inhibitor myricetin
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.12.016
Towards modern anticancer agents that interact with tubulin
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.028
Production of “biobetter” glucarpidase variants to improve drug detoxification and antibody directed enzyme prodrug therapy for cancer treatment
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.10.014
The impact of gastrointestinal mucus on nanoparticle penetration – in vitro evaluation of mucus‐penetrating nanoparticles for photodynamic therapy
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.010
Inclusion complexes of &bgr;‐cyclodextrin and polymorphs of mebendazole: Physicochemical characterization
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.012
Preparation, preliminary pharmacokinetic and brain targeting study of metformin encapsulated W/O/W composite submicron emulsions promoted by borneol
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.019
Visualization of the penetration modifying mechanism of laurocapram by Mass Spectrometry Imaging in buccal drug delivery
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.011
Hybrid Ear Cubes for local controlled dexamethasone delivery to the inner ear
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.04.045
Contribution of NHE3 and dietary phosphate to lithium pharmacokinetics
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.008
The safety profile of new antidiabetic xanthine derivatives and their chitosan based formulations
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.10.015
PIV measurements of the SimInhale benchmark case
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.025
Co‐encapsulation of acyclovir and curcumin into microparticles improves the physicochemical characteristics and potentiates in vitro antiviral action: Influence of the polymeric composition
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.02.019
On‐line rheological characterization of semi‐solid formulations
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.014
Evaluation of in‐line particle measurement with an SFT‐probe as monitoring tool for process automation using a new time‐based buffer approach
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.026
Tacrolimus‐loaded methoxy poly(ethylene glycol)‐block‐poly(D,L)‐lactic–co‐glycolic acid micelles self‐assembled in aqueous solution for treating cornea immune rejection after allogenic penetrating keratoplasty in rats
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.023
Examining P‐gp efflux kinetics guided by the BDDCS ‐ Rational selection of in vitro assay designs and mathematical models
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.005
Use of roller compaction and fines recycling process in the preparation of erlotinib hydrochloride tablets
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.036
Pharmacokinetic interaction of calcitriol with 20(S)‐protopanaxadiol in mice: Determined by LC/MS analysis
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.016
Evaluation of a transtympanic delivery system in Mus musculus for extended release steroids
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.01.020
Time dependent HPLC analysis of the product ratio of enzymatically reduced prodrug CB1954 by a modified and immobilised nitroreductase
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.001
Microbiological performance of a robotic system for aseptic compounding of cytostatic drugs
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.034
New unique PAT method and instrument for real‐time inline size characterization of concentrated, flowing nanosuspensions
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.024
Aryl‐urea fatty acids that activate the p38 MAP kinase and down‐regulate multiple cyclins decrease the viability of MDA‐MB‐231 breast cancer cells☆
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.12.015
Pharmacokinetics, bioavailability and tissue distribution study of JCC‐02, a novel N‐methyl‐D‐aspartate (NMDA) receptor inhibitor, in rats by LC‐MS/MS
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.02.018
Synthesis and structure‐activity‐relationship of 3,4‐Diaryl‐1H‐pyrrolo[2,3‐b]pyridines as irreversible Inhibitors of mutant EGFR‐L858R/T790M
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.021
A new, vasoactive hybrid aspirin containing nitrogen monoxide‐releasing molsidomine moiety
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.02.020
Breakpoint determination when multiple organisms are tested for effect targets
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.033
A novel oxazolidinone derivative PH192 demonstrates anticonvulsant activity in vivo in rats and mice
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.011
Sacubitril/valsartan (LCZ696) significantly reduces aldosterone and increases cGMP circulating levels in a canine model of RAAS activation
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.037
Spectroscopic analysis of the influence of various external factors on ethenzamide‐glutaric acid (1:1) cocrystal formation
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.03.017
Tadalafil nanocomposites as a dry powder formulation for inhalation, a new strategy for pulmonary arterial hypertension treatment
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.04.001
Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical and human in vitro models: Implication for the choice of toxicology species
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.04.004
Single‐ and multiple‐dose pharmacokinetics of the peripheral non‐narcotic antitussive moguisteine in healthy Chinese volunteers
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.029
Mitochondria‐targeting nanomedicine: An effective and potent strategy against aminoglycosides‐induced ototoxicity
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.04.027
Beta‐glucan and arabinogalactan‐based xerogels for abuse‐deterrent opioid formulations
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2019.01.003
Extraction of levetiracetam for therapeutic drug monitoring by transdermal reverse iontophoresis
来源期刊:European Journal of Pharmaceutical SciencesDOI:10.1016/j.ejps.2018.11.020